JP2003500425A - 不動化ラクトフェリン（Ｉｍ−ＬＦ）抗微生物剤及びその使用 - Google Patents

不動化ラクトフェリン（Ｉｍ−ＬＦ）抗微生物剤及びその使用

Info

Publication number
JP2003500425A
JP2003500425A JP2000620811A JP2000620811A JP2003500425A JP 2003500425 A JP2003500425 A JP 2003500425A JP 2000620811 A JP2000620811 A JP 2000620811A JP 2000620811 A JP2000620811 A JP 2000620811A JP 2003500425 A JP2003500425 A JP 2003500425A
Authority
JP
Japan
Prior art keywords
lactoferrin
food
acid
composition
salmonella
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2000620811A
Other languages
English (en)
Japanese (ja)
Other versions
JP2003500425A5 (enExample
Inventor
ナイドウ、エイ．サティアナラヤン
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of JP2003500425A publication Critical patent/JP2003500425A/ja
Publication of JP2003500425A5 publication Critical patent/JP2003500425A5/ja
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23B—PRESERVATION OF FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES; CHEMICAL RIPENING OF FRUIT OR VEGETABLES
    • A23B2/00—Preservation of foods or foodstuffs, in general
    • A23B2/70—Preservation of foods or foodstuffs, in general by treatment with chemicals
    • A23B2/725—Preservation of foods or foodstuffs, in general by treatment with chemicals in the form of liquids or solids
    • A23B2/729—Organic compounds; Microorganisms; Enzymes
    • A23B2/7295—Antibiotics
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23B—PRESERVATION OF FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES; CHEMICAL RIPENING OF FRUIT OR VEGETABLES
    • A23B2/00—Preservation of foods or foodstuffs, in general
    • A23B2/70—Preservation of foods or foodstuffs, in general by treatment with chemicals
    • A23B2/725—Preservation of foods or foodstuffs, in general by treatment with chemicals in the form of liquids or solids
    • A23B2/729—Organic compounds; Microorganisms; Enzymes
    • A23B2/783—Microorganisms; Enzymes
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23B—PRESERVATION OF FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES; CHEMICAL RIPENING OF FRUIT OR VEGETABLES
    • A23B4/00—Preservation of meat, sausages, fish or fish products
    • A23B4/14—Preserving with chemicals not covered by groups A23B4/02 or A23B4/12
    • A23B4/18—Preserving with chemicals not covered by groups A23B4/02 or A23B4/12 in the form of liquids or solids
    • A23B4/20—Organic compounds; Microorganisms; Enzymes
    • A23B4/22—Microorganisms; Enzymes; Antibiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/745—Bifidobacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/40—Transferrins, e.g. lactoferrins, ovotransferrins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/005—Antimicrobial preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00—Preparations for care of the hair
    • A61Q5/02—Preparations for cleaning the hair
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/79—Transferrins, e.g. lactoferrins, ovotransferrins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/57—Compounds covalently linked to a(n inert) carrier molecule, e.g. conjugates, pro-fragrances
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Zoology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Molecular Biology (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Wood Science & Technology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Dermatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Toxicology (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Birds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Food Preservation Except Freezing, Refrigeration, And Drying (AREA)
  • Medicinal Preparation (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Paints Or Removers (AREA)
  • Meat, Egg Or Seafood Products (AREA)
JP2000620811A 1999-05-28 2000-05-26 不動化ラクトフェリン（Ｉｍ−ＬＦ）抗微生物剤及びその使用 Pending JP2003500425A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US09/322,700 1999-05-28
US09/322,700 US6172040B1 (en) 1999-05-28 1999-05-28 Immobilized lactoferrin antimicrobial agents and the use thereof
PCT/US2000/014818 WO2000072690A2 (en) 1999-05-28 2000-05-26 IMMOBILIZED LACTOFERRIN (Im-LF) ANTIMICROBIAL AGENTS AND USES THEREOF

Publications (2)

Publication Number Publication Date
JP2003500425A true JP2003500425A (ja) 2003-01-07
JP2003500425A5 JP2003500425A5 (enExample) 2006-01-05

Family

ID=23256039

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2000620811A Pending JP2003500425A (ja) 1999-05-28 2000-05-26 不動化ラクトフェリン（Ｉｍ−ＬＦ）抗微生物剤及びその使用

Country Status (9)

Country Link
US (2) US6172040B1 (enExample)
EP (1) EP1181044B1 (enExample)
JP (1) JP2003500425A (enExample)
AT (1) ATE505200T1 (enExample)
AU (3) AU776657B2 (enExample)
BR (2) BR0011558A (enExample)
DE (1) DE60045839D1 (enExample)
IN (1) IN2001KO01249A (enExample)
WO (2) WO2000072874A1 (enExample)

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005084703A1 (ja) * 2004-03-09 2005-09-15 Nrl Pharma, Inc. 徐放性の口腔用組成物
JP2007523204A (ja) * 2004-02-24 2007-08-16 キャンピナ・ビーブイ 表面、腔、及び食品原料のための抗菌ラクトフェリン組成物
JP2009513572A (ja) * 2005-09-28 2009-04-02 ベントリア バイオサイエンス 腸管障害及び／又は下痢用の経口組成物
JP2012161310A (ja) * 2011-02-04 2012-08-30 Kajita Atsumi 食中毒を減少させるための溶液及びシステム
JP2022534775A (ja) * 2019-05-31 2022-08-03 アクイラ バイオサイエンス リミテッド 除染／消毒のためのデバイスと方法

Families Citing this family (58)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7074759B2 (en) * 1999-05-28 2006-07-11 Naidu A Satyanarayan Treatment of case-ready food products with immobilized lactoferrin (Im-LF) and the products so produced
US6172040B1 (en) * 1999-05-28 2001-01-09 A. Satyanarayan Naidu Immobilized lactoferrin antimicrobial agents and the use thereof
EP1259635A4 (en) * 2000-02-25 2004-11-24 Smithkline Beecham Corp METHODS FOR SCREENING ANTIMICROBIAL COMPOUNDS
US6919364B2 (en) * 2001-06-28 2005-07-19 Solution Biosciences, Inc. Microbiological control in animal processing
US6986910B2 (en) * 2001-06-28 2006-01-17 Albemarle Corporation Microbiological control in poultry processing
EP1441988A1 (en) * 2001-10-09 2004-08-04 Albemarle Corporation Control of biofilms in industrial water systems
CA2471766C (en) * 2001-12-28 2011-01-11 Nrl Pharma, Inc. Compositions for improving lipid metabolism
EP1478379A4 (en) * 2001-12-28 2005-12-21 Campina Bv HUMANIZED LACTOFERRIN AND ITS APPLICATIONS
EP1477182A4 (en) * 2002-01-21 2009-05-27 Nrl Pharma Inc NEW ANALGETICS
DK1480524T3 (da) * 2002-03-07 2013-07-15 Upfront Chromatography As Fremgangsmåde til isolering af lactoferrin
EP1496742B1 (en) * 2002-03-29 2010-11-24 The Research Foundation Of State University Of New York Use of non-antibacterial tetracycline analogs and formulations thereof for the treatment of bacterial exotoxins
US20030040032A1 (en) * 2002-08-23 2003-02-27 Demarsh Peter L. Methods of screening for antimicrobial compounds
US20060073216A1 (en) * 2002-12-26 2006-04-06 Solution Biosciences, Inc. Compositions and methods for control of bovine mastitis
AU2004228759B2 (en) * 2003-04-09 2010-04-08 Dolhay Klinika Egeszsegugyi Kft. Sexual hygienic composition
US7566447B2 (en) * 2003-05-15 2009-07-28 Iogenetics, Llc Biocides
US8703134B2 (en) 2003-05-15 2014-04-22 Iogenetics, Llc Targeted cryptosporidium biocides
US20050014932A1 (en) * 2003-05-15 2005-01-20 Iogenetics, Llc Targeted biocides
US8394379B2 (en) * 2003-05-15 2013-03-12 Iogenetics, Llc Targeted cryptosporidium biocides
WO2005000030A1 (en) * 2003-06-23 2005-01-06 Naidu A Satyanarayan TREATMENT OF CASE-READY FOOD PRODUCTS WITH IMMOBILIZED LACTOFERRIN (Im-LF) AND THE PRODUCTS SO PRODUCED
US7901276B2 (en) 2003-06-24 2011-03-08 Albemarle Corporation Microbiocidal control in the processing of meat-producing four-legged animals
US20040265445A1 (en) * 2003-06-24 2004-12-30 Liimatta Eric W. Microbiocidal control in the processing of poultry
US20040265446A1 (en) * 2003-06-24 2004-12-30 Mcnaughton James L. Microbiocidal control in the processing of poultry
US7125963B2 (en) * 2004-03-03 2006-10-24 En N Tech Inc Treatments for contaminant reduction in lactoferrin preparations and lactoferrin containing compositions
BRPI0510204A (pt) * 2004-05-12 2007-10-16 Du Pont filme laminado, produto e processo
FR2875501B1 (fr) * 2004-09-21 2008-02-29 Univ Paris Descartes Nouveaux derives peptidiques, compositions et utilisations dans un traitement therapeutique de l'infection par un herpesvirus
EP1812550A2 (en) * 2004-10-20 2007-08-01 Iogenetics, Llc Biocides
US7956031B2 (en) 2005-05-31 2011-06-07 Naidu Lp Metallo-lactoferrin-coenzyme compositions for trigger and release of bioenergy
TWI407913B (zh) * 2005-12-01 2013-09-11 Albemarle Corp 加工處理四腳屠宰動物及/或衍生自四腳屠宰動物之生肉品之方法
GB0525504D0 (en) 2005-12-14 2006-01-25 Bristol Myers Squibb Co Antimicrobial composition
US8021659B2 (en) * 2006-04-28 2011-09-20 Naidu Lp Coenzyme Q10, lactoferrin and angiogenin compositions and uses thereof
TW200808191A (en) * 2006-08-09 2008-02-16 Genmont Biotech Inc Product containing Lactobacillus paracasei
WO2008047391A1 (en) * 2006-10-17 2008-04-24 S.I.F.Fr.A. Farmaceutici Srl Nutriceutic composition comprising lactoferrin and proteasic probiotics
US8828698B2 (en) * 2007-04-12 2014-09-09 Naidu Lp Immobilized angiogenin mixtures and uses thereof
US7601689B2 (en) 2007-04-12 2009-10-13 Naidu Lp Angiogenin complexes (ANGex) and uses thereof
NZ583234A (en) 2007-07-10 2012-06-29 Glanbia Nutritionals Method for removing endotoxin from proteins
US20090098254A1 (en) * 2007-10-12 2009-04-16 Robert Ty Baublits Methods And Compositions For Improving Sensory And Shelf Life Characteristics Of Raw Meat Products
JP4246777B1 (ja) 2007-11-20 2009-04-02 森永乳業株式会社 異常型プリオン蛋白質結合剤および異常型プリオン蛋白質の検出方法
US8309080B2 (en) * 2007-12-06 2012-11-13 Naidu Lp Metallo-protein and tocotrienol (MP-T3) compositions and uses thereof
US8840883B2 (en) 2007-12-06 2014-09-23 Naidu Lp Metallo-protein and tocotrienol (MP-T3) compositions with non-protein-type metal chelator and uses thereof
US20090155328A1 (en) * 2007-12-14 2009-06-18 E. I. Du Pont De Nemours And Company Films comprising antimicrobial and fungistatic agents
WO2009092383A2 (en) 2008-01-22 2009-07-30 Multimerics Aps Products and methods to prevent infection
EP2300603A4 (en) * 2008-06-24 2011-08-03 Micropharma Ltd OXIDE DEVICE AND METHOD FOR WOUND HEALING, TREATMENT OF SKIN DISEASES AND MICROBIAL INFECTIONS
DK2297577T3 (da) * 2008-06-25 2017-11-06 Lilly Co Eli Fremgangsmåder og systemer til forøgelse af fødevaresikkerheden af protein
US9359426B2 (en) 2009-04-24 2016-06-07 Westland Co-Operative Diary Company Limited Method of preparing low-iron lactoferrin
WO2010137015A2 (en) 2009-05-25 2010-12-02 Oplon B.V Bioactive container
WO2011067762A2 (en) 2009-12-02 2011-06-09 Oplon B.V. Extended shelf-life liquids and method thereof
ES2388478T3 (es) * 2009-12-02 2012-10-15 Bettina Heil Supositorio para la administración rectal, vaginal o uretral que contiene un probiótico, un antibiótico y un ácido graso insaturado no esterificado
GB201020236D0 (en) 2010-11-30 2011-01-12 Convatec Technologies Inc A composition for detecting biofilms on viable tissues
GB201107068D0 (en) * 2011-04-26 2011-06-08 Univ Birmingham Prebiotic agent
JP2016507663A (ja) 2012-12-20 2016-03-10 コンバテック・テクノロジーズ・インコーポレイテッドＣｏｎｖａｔｅｃ Ｔｅｃｈｎｏｌｏｇｉｅｓ Ｉｎｃ 化学修飾セルロース系繊維の加工
CN103190470B (zh) * 2013-03-24 2015-09-09 新疆农垦科学院 一种肉类复合生物保鲜剂及其制备方法
EP3046574A1 (en) * 2013-09-02 2016-07-27 Nestec S.A. Lactoferrin and memory and learning speed in children
BR112018076609B1 (pt) 2016-12-15 2023-02-14 Société des Produits Nestlé S.A. Composição alimentícia para animais de estimação, seus usos, e métodos não terapêutico para modular a quantidade e para medição de uma alteração na quantidade de pelo menos uma dentre bifidobacterium, lactobacillus ou clostridium perfringens
CN109090107B (zh) * 2018-10-25 2021-08-24 江苏省农业科学院 植物蛋白源成膜性农药助剂及其制备方法和应用
CN109259106B (zh) * 2018-10-26 2022-05-10 福建农林大学 一种基于多次发酵提高羊肉嫩度的方法
MX2021013177A (es) * 2019-05-06 2022-03-04 Native Microbials Inc Metodos para mejorar el tratamiento del colico equino mediante la administracion de un bioensamblaje sintetico o cepas purificadas de este.
WO2022271002A1 (es) 2021-06-23 2022-12-29 Kuragobiotek Holdings Sapi De Cv Alimento en fermentación dinámica controlada para bacteriostasis de microorganismos benéficos manteniéndolos vivos y metabólicamente activos para consumo humano
US20240041073A1 (en) * 2022-08-05 2024-02-08 Jung Ju Mun Method for manufacturing processed food

Family Cites Families (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB443911A (en) * 1933-09-07 1936-03-09 Fruit Growers Exchange Ca Improvements in or relating to food preservative means
IL25140A (en) 1965-02-15 1970-01-29 Vaessen Schoemaker Holding Bv Additives and methods for improving the quality of protein containing nutrients
NL6604815A (enExample) 1966-04-12 1967-10-13
US4545933A (en) 1980-08-20 1985-10-08 Ernster John H Hydrolyzed protein composition and process used in preparation thereof
JPS60145067A (ja) 1984-01-09 1985-07-31 Takeda Chem Ind Ltd 肉類食品の退色防止方法および退色防止用組成物
BE901672A (fr) 1985-02-07 1985-08-07 Oleofina Sa Procede de purification de proteines du lait et de ses derives.
US4683139A (en) 1985-07-11 1987-07-28 Wilson Foods Corporation Process for prepacking fresh meat
IE61701B1 (en) 1986-07-17 1994-11-30 Morinaga Milk Industry Co Ltd Process for producing bovine lactoferrin in high purity
JP2631470B2 (ja) 1987-05-15 1997-07-16 雪印乳業株式会社 感染防御剤
FR2616628B1 (fr) 1987-06-19 1989-09-29 Entremont Sa Procede pour extraire des proteines du lactoserum par adsorption et elution
US5573801A (en) * 1989-02-21 1996-11-12 Viskase Corporation Surface treatment of foodstuffs with antimicrobial compositions
EP0389795B1 (en) * 1989-02-25 1993-06-23 Morinaga Milk Industry Co., Ltd. Bioactive lactoferrin derivates
FR2646777B1 (fr) * 1989-05-12 1993-09-03 Bio Serae Lab Procede de preparation d'un produit particulaire antimicrobien, produit antimicrobien obtenu et applications
JPH0646926B2 (ja) 1989-08-24 1994-06-22 雪印乳業株式会社 低カロリー肉製品及びその製造方法
DE69004242T2 (de) 1990-01-23 1994-05-05 Morinaga Milk Industry Co Ltd Laktoferrinhydrolysat zur Verwendung als antibakterielles Mittel.
US6066469A (en) * 1990-03-08 2000-05-23 Ferro Dynamics, Inc. Cloning, expression, and uses of human lactoferrin
AU7453391A (en) * 1990-03-08 1991-10-10 Ferrodynamics, Inc. Genetically engineered human lactoferrin
JP2974434B2 (ja) 1990-03-15 1999-11-10 雪印乳業株式会社 分泌性コンポネント含有組成物
US5015487A (en) * 1990-04-23 1991-05-14 Haarmann & Reimer Corp. Use of lanthionines for control of post-processing contamination in processed meat
US5156875A (en) 1991-06-17 1992-10-20 Doyle W. Boatwright Stabilized antimicrobial food composition
US5656591A (en) 1992-01-23 1997-08-12 Morinaga Milk Industry Co., Ltd. Antimicrobial agents and method for treating products therewith
JPH06145068A (ja) * 1992-04-02 1994-05-24 Imuno Japan:Kk 生体防御能賦活剤・感染症治療剤・生体防御能賦活性食品
JPH0648955A (ja) * 1992-07-29 1994-02-22 Morinaga Milk Ind Co Ltd 消化管細胞賦活化剤
JP2835902B2 (ja) 1993-02-16 1998-12-14 雪印乳業株式会社 耐熱性ラクトフェリン−鉄結合体及びその製造法
RU2099065C1 (ru) 1994-09-23 1997-12-20 Московский научно-исследовательский онкологический институт им. П.А.Герцена МЗ РФ Препарат для лечения местных осложнений консервативного противоопухолевого лечения в орофарингеальной зоне и способ лечения осложнений консервативного противоопухолевого лечения в орофарингеальной зоне
JP2832517B2 (ja) * 1994-12-09 1998-12-09 雪印乳業株式会社 大腸菌付着阻止剤
IT1278136B1 (it) * 1995-07-12 1997-11-17 Piera Valenti Associazione costituita dsa lattoferrina (o suoi analoghi) e deferossamina metalsulfonato (o altri chelanti ioni metallici) per
US5834424A (en) 1995-07-12 1998-11-10 Gambit International Limited Use of lactoferrin for therapy of acute of chronic infectious diseases by the intracellular gram-positive pathogens streptococcus pyogenes and staphylococcus aureus
IT1278137B1 (it) * 1995-07-12 1997-11-17 Piera Valenti Utilizzo della lattoferrina per la terapia topica delle infezioni acute o recidivanti causate da "streptococcus pyogenes" o da altri
DE19624704A1 (de) * 1996-06-20 1998-01-08 Klinge Co Chem Pharm Fab Neue Pyridylalkansäureamide
US5714188A (en) 1996-09-12 1998-02-03 Gilchrist; Caleb L. Method of processing meat
US5780085A (en) 1996-10-04 1998-07-14 Hormel Foods Corporation Chemical treatment and packaging process to improve the appearance and shelf life of fresh pork
US6258383B1 (en) * 1998-08-14 2001-07-10 Lactoferrin Products Company Dietary supplement combining colostrum and lactoferrin in a mucosal delivery format
US6172040B1 (en) * 1999-05-28 2001-01-09 A. Satyanarayan Naidu Immobilized lactoferrin antimicrobial agents and the use thereof
DE10161170A1 (de) * 2001-12-13 2003-06-18 Beiersdorf Ag Lippenstift
EP1478379A4 (en) * 2001-12-28 2005-12-21 Campina Bv HUMANIZED LACTOFERRIN AND ITS APPLICATIONS

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2007523204A (ja) * 2004-02-24 2007-08-16 キャンピナ・ビーブイ 表面、腔、及び食品原料のための抗菌ラクトフェリン組成物
WO2005084703A1 (ja) * 2004-03-09 2005-09-15 Nrl Pharma, Inc. 徐放性の口腔用組成物
JP2009513572A (ja) * 2005-09-28 2009-04-02 ベントリア バイオサイエンス 腸管障害及び／又は下痢用の経口組成物
JP2013139477A (ja) * 2005-09-28 2013-07-18 Ventria Bioscience 経口投与される剤
JP2012161310A (ja) * 2011-02-04 2012-08-30 Kajita Atsumi 食中毒を減少させるための溶液及びシステム
JP2022534775A (ja) * 2019-05-31 2022-08-03 アクイラ バイオサイエンス リミテッド 除染／消毒のためのデバイスと方法
JP7676026B2 (ja) 2019-05-31 2025-05-14 アクイラ バイオサイエンス リミテッド 除染／消毒のためのデバイスと方法

Also Published As

Publication number Publication date
EP1181044B1 (en) 2011-04-13
DE60045839D1 (de) 2011-05-26
WO2000072690A3 (en) 2001-05-10
BR0011021A (pt) 2003-04-29
IN2001KO01249A (enExample) 2005-03-11
BR0011558A (pt) 2002-02-26
AU776657B2 (en) 2004-09-16
EP1181044A2 (en) 2002-02-27
AU5303500A (en) 2000-12-18
US7375080B1 (en) 2008-05-20
ATE505200T1 (de) 2011-04-15
US6172040B1 (en) 2001-01-09
AU5449100A (en) 2000-12-18
WO2000072690A2 (en) 2000-12-07
AU2003204900A1 (en) 2003-07-24
WO2000072874A1 (en) 2000-12-07

Similar Documents

Publication Publication Date Title
AU776657B2 (en) Immobilized lactoferrin (Im-LF) antimicrobial agents and uses thereof
Mkangara Prevention and control of human Salmonella enterica infections: An implication in food safety
Rad et al. Postbiotics, as dynamic biomolecules, and their promising role in promoting food safety
Ben Braiek et al. Enterococci: between emerging pathogens and potential probiotics
Franz et al. Enterococci at the crossroads of food safety?
Ammar et al. Campylobacter as a major foodborne pathogen: A review of its characteristics, pathogenesis, antimicrobial resistance and control
US7074759B2 (en) Treatment of case-ready food products with immobilized lactoferrin (Im-LF) and the products so produced
Linton et al. Antibiotic resistance among Escherichia coli O‐serotypes from the gut and carcasses of commercially slaughtered broiler chickens: a potential public health hazard
Kanaan et al. Prevalence of multidrug resistant thermotolerant species of Campylobacter in Retail Frozen Chicken meat in Baghdad Province
JP2002503084A (ja) 腸管病原性細菌を減少させるための家畜粘膜の競争排除培養
Bezirtzoglou, Vassiliki Maipa, Chrissoula Voidarou, Arsenis Tsiotsias, Maria Papapetropoulou Food-borne intestinal bacterial pathogens
Anum et al. Foodborne pathogens: An introduction
Ghosh et al. Antibiotic resistance in Enterococci: A food safety perspective
Hrustemović et al. Food pathogen of broiler chicken meat Campylobacter spp. and antibiotic resistance.
Narbad et al. Lactic acid bacteria and foodborne pathogens
Arias-Rios et al. Natural food antimicrobials of animal origin
Sickenga Transmission of salmonellae and pathogenesis of salmonellosis in man
Upadhyay Investigating the potential of plant-derived antimicrobials and probiotic bacteria for controlling Listeria monocytogenes
Simjee et al. Enterococcus
Boutin et al. Evaluation of the enteropathogenicity of Klebsiella pneumoniae isolates from summer-harvested Louisiana oysters
Shapwa Antimicrobial effect of selected probiotic strains on salmonella typhimurium and e. coli o157: h7 isolated in a commercial slaughterhouse in Windhoek, Namibia
Hakeem Innovative strategies for the control of Campylobacter jejuni in agri-foods
Neetoo Effectiveness of antimicrobial packaging in controlling the growth of listeria monocytogenes on cold-smoked salmon
KR20190074702A (ko) 신규한 시가톡신 생성 대장균 특이 박테리오파지 ecoh1 및 이를 포함하는 항균 조성물
Hamedani et al. Effects of Alginate Coating and Neutral Electrolyzed Water on E. coli O 157: H 7 Contamination of Salmon Fillets.

Legal Events

Date Code Title Description
A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20041209

A625 Written request for application examination (by other person)

Free format text: JAPANESE INTERMEDIATE CODE: A625

Effective date: 20041209

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A821

Effective date: 20041209

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20050317

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20050929

A871 Explanation of circumstances concerning accelerated examination

Free format text: JAPANESE INTERMEDIATE CODE: A871

Effective date: 20050929

A975 Report on accelerated examination

Free format text: JAPANESE INTERMEDIATE CODE: A971005

Effective date: 20051021

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A821

Effective date: 20050929

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20051206

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20060306

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20060313

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20060531

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20060623